Navigation Links
Sigma-Aldrich and Sangamo BioSciences Announce the Achievement of Key Throughput Milestone in Research Reagents Agreement
Date:1/12/2009

="_new">zfn@sial.com.

About Sigma-Aldrich

Sigma-Aldrich is a leading Life Science and High Technology company. Its biochemical and organic chemical products and kits are used in scientific and genomic research, biotechnology, pharmaceutical development, the diagnosis of disease and as key components in pharmaceutical and other high technology manufacturing. The Company has customers in life science companies, university and government institutions, hospitals, and in industry. Over one million scientists and technologists use its products. Sigma-Aldrich operates in 36 countries and has 8,000 employees providing excellent service worldwide. Sigma-Aldrich is committed to Accelerating Customer Success through Innovation and Leadership in Life Science, High Technology and Service. For more information about Sigma-Aldrich, please visit its award-winning Web site at http://www.sigma-aldrich.com.

About Sangamo

Sangamo BioSciences, Inc. is focused on the research and development of novel DNA-binding proteins for therapeutic gene regulation and modification. The most advanced ZFP Therapeutic(TM) development program is currently in Phase 2 clinical trials for evaluation of safety and clinical effect in patients with diabetic neuropathy and ALS. Other therapeutic development programs are focused on stem cell mobilization, HIV/AIDS, cancer, neuropathic pain, Parkinson's disease and monogenic diseases. Sangamo's core competencies enable the engineering of a class of DNA-binding proteins known as zinc finger DNA-binding proteins (ZFPs). By engineering ZFPs that recognize a specific DNA sequence Sangamo has created ZFP transcription factors (ZFP TF(TM)) that can control gene expression and, consequently, cell function. Sangamo is also developing sequence-specific ZFP Nucleases (ZFN(TM)) for gene modifi
'/>"/>

SOURCE Sangamo BioSciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Sigma-Aldrich (Nasdaq: SIAL) Declares Quarterly Dividend
2. Sigma-Aldrich and Lab Manager Magazine Present Webinar On Laboratory Environmental, Health and Safety Compliance Strategies
3. Sigma-Aldrich Expansion in Republic of China to Support SAFC Growth
4. Sigma-Aldrich and Ingenuity Systems Announce Partnership to Create E-Commerce Search Solution Based on Biological Knowledge
5. Sigma-Aldrich to Present at the UBS 2007 Global Life Sciences Conference on September 25, 2007
6. Sigma-Aldrich Names Patrick Sullivan New VP of Research and Development for Research Biotech
7. Sigma-Aldrich and the Universite de Montreal Establish Collaboration for RNA Interference Studies
8. Sigma-Aldrich Corporations 3rd Quarter 2007 Earnings Conference Call
9. Sigma-Aldrich Introduces N-TER Nanoparticle siRNA Transfection System for Delivery of siRNA Into Difficult-to-Transfect Cell Types
10. Sigma-Aldrich (Nasdaq: SIAL) Q3 2007 Sales Increase 14.0%, Yielding Diluted EPS of $.54.
11. Sigma-Aldrich and Oxford BioMedica Win Key Ruling in Open Biosystems Patent Infringement Dispute

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/8/2009)...ber 6, 2009 As global temperatures and energy cos...ill be key to a sustainable future. An attractiv...studies published online in Genome Research ( ww...e structures of bioethanol-producing microorganism...in developing new technologies needed to implement...
(Date:11/6/2009)...YNBROOK, N.Y., Nov. 6 Bi...biopharmaceutical company developing first-in-clas...financial results for the third quarter ended Sept...at, in September of this year, the FDA,s Arthritis...vote of 12-0, the approval of XIAFLEX(TM) for the ...
(Date:11/6/2009)...AN MATEO, Calif., Nov. 6 ...leted transfer of Qutenza(TM) E.U. Marketing Autho...nificant progress in commercial readiness activiti...Senior Director, Marketing; and Director, Commerci...ard as director and Audit Committee chairman ,...
(Date:11/6/2009)... The agenda for Arrowhead’...ce, which is set to take place on February 22-24, ...three day conference we will highlight key issues ...rs to share their experiences. , ...- The agenda for Arrowhead’s 2010 Personali...
Breaking Biology Technology:Genomes of biofuel yeasts reveal clues that could boost fuel ethanol production worldwide 2Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 6NeurogesX Reports Third Quarter 2009 Results 2NeurogesX Reports Third Quarter 2009 Results 3NeurogesX Reports Third Quarter 2009 Results 4NeurogesX Reports Third Quarter 2009 Results 5NeurogesX Reports Third Quarter 2009 Results 6NeurogesX Reports Third Quarter 2009 Results 7NeurogesX Reports Third Quarter 2009 Results 8NeurogesX Reports Third Quarter 2009 Results 9NeurogesX Reports Third Quarter 2009 Results 10Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 3
...n venture capital investment for 2005 from 26th in...ationally, venture capital recorded by the survey ... 2004,s total. , ,According to MoneyTree, 10 Wisco...ure investments in 2005, while nine companies brou...data on Wisconsin is historically not a smooth tre...
...ate that we continue to review biotech results for...elp us discern trends for 2006. , ,Another researc...s is Burrill & Co. ,s financial tracking informat...ike about Burrill is that he continues over the ye...eerleaders. , ,Another aspect is that he is usuall...
...rkshops , the renowned photography school in Santa... I was the guest of a very gracious Kodak. The obj...all group of us who write and talk about digital i...f digital photography, while along the way becomin...a and EasyShare desktop software and photo shar...
Other Biology Technology:2005 was a tough year for U.S. biotech financing 22005 was a tough year for U.S. biotech financing 32005 was a tough year for U.S. biotech financing 42005 was a tough year for U.S. biotech financing 5Photography is in the seeing, not the technology 2Photography is in the seeing, not the technology 3
(Date:11/9/2009)...ction method that begins by soaking corn kernels r...of ethanol and more usable co-products, giving eth...out 20 percent. , "The conventional ethanol prod...illers dried grains with soluble, it doesn,t have ...s Agricultural Engineer Esha Khullar. "Whereas in ...
(Date:11/9/2009)...ogists David Queller and Joan Strassmann argue in ... between components, from the genetic level on up,...that thing is an animal, a plant, a bacteria or a...describe an organism, such as individuality or eve...sary to achieve organismality. What is necessary, ...
(Date:11/9/2009)...9, 2009 / b3c newswire / - Today, TNO, a Dutch ...an American organization for contract research and...ned a letter of intent with regard to TNOs dynamic...r of intent proposes a collaboration in which Seve...lization in North America. The TIM systems will be...
Breaking Biology News(10 mins):Wet ethanol production process yields more ethanol and more co-products 2What is the meaning of 'one'? 2What is the meaning of 'one'? 3TNO and Seventh Wave sign letter of intent on joint preclinical pharmaceutical outsourcing services 2SK Life Sciences has Licensed Pristima 13368 1SK Life Sciences has Licensed Pristima 13368 2New Book Helps Those with Bipolar Disorder Manage Diets and Lives 53692 1New Book Helps Those with Bipolar Disorder Manage Diets and Lives 53692 2Andrew Allen joins Navvis 26amp 3B Company 53689 1Andrew Allen joins Navvis 26amp 3B Company 53689 2
...ey have identified a gene that appears to play a k...o known as insulin-dependent or juvenile diabetes,...n the U.S. and is on the rise worldwide. They desc... new drug interventions and possibly gene therapy,...an Chemical Society, the world,s largest scientifi...
...resonance spectroscopy (MRS) for the first time to...ng human heart, Johns Hopkins researchers have fou..., The findings, published in the January 18 issue...ences, confirm what many scientists have conjectur...treatments designed to reduce energy demand and/or...
...bolism of fat is an important challenge for any an... the regulatory network are the nuclear hormone re...at turn on or off a set of target genes when bound...access journal PLoS Biology, Keith Yamamoto and co...r-49 controls two different aspects of fat metabol...
Other Biology News:Chemists identify key gene in development of type 1 diabetes 2Chemists identify key gene in development of type 1 diabetes 3Special Imaging Study Shows Failing Hearts Are 'Energy Starved' 2Opposing fat metabolism pathways triggered by a single gene 2
... Hummingbird has the ability to quickly and accura...es it a perfect candidate for inclusion in these h...X interface supplied with all the Cartesian produc...re. Hummingbirds ability to copy plates in second...
Benchtop Ductless Exhaust Hood (Universal Hood) from Terra Universal, Inc.
...el IT siRNA Tracker Intracellular Localization Kit...s a straight forward approach to directly label an...et non-destructive manner, for in vitro tracking e...l inhibition of target gene expression can be moni...
...us preparative LC/MS, using mass numbers as a trig...t ideal for performing investigation and research ... for both analytical and preparative operation. Sw... software. This support provides a quick solution ...
Biology Products: